BioMelbourne Network Welcomes Revisions to Skilled Migration Visas
Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to the Medium…
Read MoreMay 2017 – Department of Immigration Roundtable Discussion
BioMelbourne Network CEO, Dr Krystal Evans attended a technology industries roundtable discussion with the Department of Immigration and the Department of Industry regarding skilled migration and the decision to abolish the 457 visa program. The medical technology, biotechnology and…
Read MoreJoint statement on the Research & Development Tax Incentive 18 April 2017
Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…
Read MoreSeptember 2016 – Changes to the R&D Tax Incentive: Putting a handbrake on innovation
The R&D Tax Incentive Review paper was released on 28th of September, making recommendations on changes to the scheme – including a proposed $2Million cap on the annual cash refund payable under the R&D Tax Incentive. The proposed…
Read MoreBioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee
The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for Melbourne’s membership,…
Read MoreSeptember 2016 – MTP Connect Competitiveness Plan Consultation Lunch
A new pathway for engagement with the Federal Government on issues concerning the sector is through the recently established Industry Growth Centres. Last week, BioMelbourne Network held a CEO lunch with Sue MacLeman, CEO MTPConnect as a roundtable…
Read MoreAugust 2016 – Nature 2016 Research Translation and Innovation Symposium
Leadership | Culture | Communication | Collaboration | Human Capital | Scale These were the strong themes emerging from the Nature 2016 Research Translation and Innovation Symposium held in Canberra last week on Thursday 11th of August. The…
Read More10 year sector competitiveness plan for Medical Technologies and Pharmaceuticals
We want to know if we’ve got it right, said Sue MacLeman, CEO of MTPConnect at the launch of the 10 year Sector Competitiveness Plan – which is still in draft form. The plan outlines seven Sector Growth…
Read MoreJuly 2016 – Launch Vic Collaboration
BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch Vic are…
Read MoreJuly 2016 – Meeting with the Hon Wade Noonan MP
BioMelbourne Network CEO, Dr Krystal Evans and Chair, Mr Andrew Carter held an introductory meeting with the Hon Wade Noonan, Minister for Industry and Employment. Minister Noonan was appointed into this role in May and has portfolio responsibilities…
Read MoreJuly 2016 – Two new strategies launched
In July, Victorian Health Minister Jill Hennessy launched two new government strategies: Victoria’s Health and Medical Research Strategy 2016-20: Healthier lives, stronger economy Victoria’s International Health Strategy 2016 – 2020: Partnering for a healthy and prosperous future These strategies…
Read MoreJune 2016 – NISA Engagement and Impact Assessment Consultation Paper
The BioMelbourne Network welcomed the opportunity to contribute a submission in response to the National Innovation & Science Agenda (NISA) Engagement and Impact Assessment Consultation Paper. Research engagement and impact is a very important issue for BioMelbourne Network members…
Read More
